120 related articles for article (PubMed ID: 36550905)
1. To study the mechanism of panax notoginseng in the treatment of aspirin resistance in the secondary prevention of stroke based on TLR4/MyD88/NF-κB signaling pathway: A study protocol.
Wang H; Yuan J; Wang Y; Chen J
Medicine (Baltimore); 2022 Dec; 101(50):e31919. PubMed ID: 36550905
[TBL] [Abstract][Full Text] [Related]
2. Combination of Panax notoginseng saponins and aspirin potentiates platelet inhibition with alleviated gastric injury via modulating arachidonic acid metabolism.
Wang W; Yang L; Song L; Guo M; Li C; Yang B; Wang M; Kou N; Gao J; Qu H; Ma Y; Xue M; Shi D
Biomed Pharmacother; 2021 Feb; 134():111165. PubMed ID: 33370633
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of butylphthalide in secondary prevention of stroke: study protocol for a multicenter, real world trial based on Internet.
Lv J; Zhao D; Zhao G; Xie Z
BMC Neurol; 2022 Aug; 22(1):305. PubMed ID: 35986234
[TBL] [Abstract][Full Text] [Related]
4. Chinese herbal compound prescriptions combined with Chinese medicine powder based on traditional Chinese medicine syndrome differentiation for treatment of chronic atrophic gastritis with erosion: a multi-center, randomized, positive-controlled clinical trial.
Zhang T; Zhang B; Xu J; Ren S; Huang S; Shi Z; Guo S; Bian L; Wang P; Wang F; Cai Y; Tang X
Chin Med; 2022 Dec; 17(1):142. PubMed ID: 36550503
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke (ATAMIS): a parallel, randomised, open-label, multicentre, prospective study.
Hou X; Li X; Wang X; Chen H
Stroke Vasc Neurol; 2018 Dec; 3(4):263-267. PubMed ID: 30637134
[TBL] [Abstract][Full Text] [Related]
6. [Intervention mechanism of electroacupuncture in rats with ulcerative colitis: an analysis based on the Toll-like receptor 4/myeloid differentiation factor 88/nuclear factor-kappa B signaling pathway].
Qiao CX; Zhao G; Zhang LZ; Di AT; Liu PL; Wang YY; Zeng L
Zhen Ci Yan Jiu; 2020 Mar; 45(3):180-7. PubMed ID: 32202708
[TBL] [Abstract][Full Text] [Related]
7. Guanxinning tablet for patients who switch from dual antiplatelet therapy to aspirin alone after percutaneous coronary intervention: study protocol for a cluster randomized controlled trial.
Li J; Ju J; Chen Z; Liu J; Lu F; Gao R; Xu H
Trials; 2018 Feb; 19(1):93. PubMed ID: 29415754
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis.
Farrant M; Easton JD; Adelman EE; Cucchiara BL; Barsan WG; Tillman HJ; Elm JJ; Kim AS; Lindblad AS; Palesch YY; Zhao W; Pauls K; Walsh KB; Martí-Fàbregas J; Bernstein RA; Johnston SC
JAMA Netw Open; 2019 Sep; 2(9):e1910769. PubMed ID: 31490536
[TBL] [Abstract][Full Text] [Related]
9. Radix/rhizoma notoginseng extract (sanchitongtshu) for ischemic stroke: a randomized controlled study.
He L; Chen X; Zhou M; Zhang D; Yang J; Yang M; Zhou D
Phytomedicine; 2011 Apr; 18(6):437-42. PubMed ID: 21094030
[TBL] [Abstract][Full Text] [Related]
10. Triflusal and aspirin in the secondary prevention of atherothrombotic ischemic stroke: a very long-term follow-up.
Alvarez-Sabín J; Quintana M; Santamarina E; Maisterra O
Cerebrovasc Dis; 2014; 37(3):181-7. PubMed ID: 24503927
[TBL] [Abstract][Full Text] [Related]
11. Combination of Xuesaitong and Aspirin Based on the Antiplatelet Effect and Gastrointestinal Injury: Study Protocol for a Randomized Controlled Noninferiority Trial.
Zhu BC; Xue CM; Lang R; Weng WL; Wang XJ; Lei ZZ; Zhang SS; Yang WH; Zhang WT; Hua GD
Evid Based Complement Alternat Med; 2021; 2021():5552506. PubMed ID: 34335822
[TBL] [Abstract][Full Text] [Related]
12. Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles.
Lin J; Han Z; Wang C; Yi X; Chai Z; Zhou Q; Huang R
Eur J Clin Pharmacol; 2018 Sep; 74(9):1131-1140. PubMed ID: 29804161
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet drug resistance is associated with early neurological deterioration in acute minor ischemic stroke in the Chinese population.
Yi X; Wang C; Liu P; Fu C; Lin J; Chen Y
J Neurol; 2016 Aug; 263(8):1612-9. PubMed ID: 27260294
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of lumbrokinase plus aspirin versus aspirin alone for acute ischemic stroke (LUCENT): study protocol for a multicenter randomized controlled trial.
Chen Y; Liu Y; Zhang J; Zhou K; Zhang X; Dai H; Yang B; Shang H
Trials; 2022 Apr; 23(1):285. PubMed ID: 35410433
[TBL] [Abstract][Full Text] [Related]
15. Renshen Shouwu extract enhances neurogenesis and angiogenesis via inhibition of TLR4/NF-κB/NLRP3 signaling pathway following ischemic stroke in rats.
Li Y; Liang W; Guo C; Chen X; Huang Y; Wang H; Song L; Zhang D; Zhan W; Lin Z; Tan H; Bei W; Guo J
J Ethnopharmacol; 2020 May; 253():112616. PubMed ID: 32007631
[TBL] [Abstract][Full Text] [Related]
16. Treatment Effect of Clopidogrel Plus Aspirin Within 12 Hours of Acute Minor Stroke or Transient Ischemic Attack.
Li Z; Wang Y; Zhao X; Liu L; Wang D; Wang C; Meng X; Li H; Pan Y; Wang X; Wang C; Yang X; Zhang C; Jing J; Xian Y; Johnston SC; Wang Y;
J Am Heart Assoc; 2016 Mar; 5(3):e003038. PubMed ID: 27001965
[TBL] [Abstract][Full Text] [Related]
17. Panax notoginseng saponin is superior to aspirin in inhibiting platelet adhesion to injured endothelial cells through COX pathway in vitro.
Wang MM; Xue M; Xu YG; Miao Y; Kou N; Yang L; Zhang Y; Shi DZ
Thromb Res; 2016 May; 141():146-52. PubMed ID: 27043068
[TBL] [Abstract][Full Text] [Related]
18. Panax notoginseng preparation plus aspirin
Dai L; Zhang Y; Jiang Y; Chen K
Front Pharmacol; 2022; 13():1015048. PubMed ID: 36569332
[No Abstract] [Full Text] [Related]
19. Safflower yellow pigment and Sanqi
Li Y; Lin Y; Shi Z; Hu Y; Shao T; Li M; Zhu J; Sun L; Chang F
Ann Transl Med; 2021 Sep; 9(18):1407. PubMed ID: 34733959
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial.
Ghati N; Roy A; Bhatnagar S; Bhati S; Bhushan S; Mahendran M; Thakur A; Tiwari P; Dwivedi T; Mani K; Gupta R; Mohan A; Garg R; Saxena A; Guleria R; Deepti S
Trials; 2020 Oct; 21(1):902. PubMed ID: 33126910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
